Soleus Capital Management, L.P. Cv Rx, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.22 Billion
- Q1 2024
A detailed history of Soleus Capital Management, L.P. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 48,500 shares of CVRX stock, worth $581,515. This represents 0.07% of its overall portfolio holdings.
Number of Shares
48,500Holding current value
$581,515% of portfolio
0.07%Shares
6 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$49.2 Million15.74% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$28.4 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$9.17 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL619KShares$7.42 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$7.13 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $247M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...